Notice2023-21588
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 2, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 189 (Monday, October 2, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 189 (Monday, October 2, 2023)]
[Notices]
[Pages 67773-67774]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-21588]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Arthritis
and Musculoskeletal and Skin Diseases Advisory Council.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The meeting
[[Page 67774]]
can be accessed from the NIH Videocast at the following link: <a href="https://videocast.nih.gov/">https://videocast.nih.gov/</a>.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Arthritis and Musculoskeletal and
Skin Diseases Advisory Council.
Date: January 30, 2024.
Open: 9 a.m. to 1 p.m.
Agenda: Discussion of Program Policies and Issues.
Place: National Institutes of Health, Building 31, 6C Room A & B
31, Center Drive, Bethesda, MD 20892, (Hybrid Meeting).
Closed: 2 to 4 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Building 31, 6C Room A & B
31, Center Drive, Bethesda, MD 20892.
Contact Person: Darren D. Sledjeski, Ph.D., Director Division of
Extramural Activities (DEA), National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701 Democracy BLVD, Bethesda, MD
20892, (301) 451-7766, <a href="/cdn-cgi/l/email-protection#94f0f5e6e6f1fabae7f8f1f0fef1e7fffdd4fafdfcbaf3fbe2"><span class="__cf_email__" data-cfemail="afcbceddddcac181dcc3cacbc5cadcc4c6efc1c6c781c8c0d9">[email protected]</span></a>.
In the interest of security, NIH has procedures at <a href="https://www.nih.gov/about-nih/visitor-information/campus-access-security">https://www.nih.gov/about-nih/visitor-information/campus-access-security</a> for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: <a href="https://www.niams.nih.gov/about/working-groups/advisory-council">https://www.niams.nih.gov/about/working-groups/advisory-council</a>, where an agenda and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: September 26, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21588 Filed 9-29-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 2, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.